C
Chihiro Morishima
Researcher at University of Washington Medical Center
Publications - 2
Citations - 5
Chihiro Morishima is an academic researcher from University of Washington Medical Center. The author has contributed to research in topics: Antigen & Cytotoxic T cell. The author has an hindex of 1, co-authored 2 publications receiving 4 citations.
Papers
More filters
Posted ContentDOI
Anti-SARS-CoV-2 antibody levels are concordant across multiple platforms but are not fully predictive of sterilizing immunity
Ben T Bradley,Andrew Bryan,Susan L Fink,Erin A. Goecker,Pavitra Roychoudhury,Meei-Li Huang,Haiying Zhu,Anu Chaudhary,Bhanupriya Madarampalli,Joyce Y-C Lu,Kathy Strand,Estella Whimbey,Chloe Bryson-Cahn,Adrienne Schippers,Nandita S Mani,Gregory Pepper,Keith R. Jerome,Keith R. Jerome,Chihiro Morishima,Robert W. Coombs,Mark H. Wener,Seth A Cohen,Alexander L. Greninger,Alexander L. Greninger +23 more
TL;DR: In this paper, the performance characteristics of the recently FDA authorized semi-quantitative anti-spike AdviseDx SARS-CoV-2 IgG II assay compared to the FDA authorized anti-nucleocapsid Abbott Architect SARS CoV2 IgG, Roche elecsys Anti-SARS-coV-1-2-S, EuroImmun anti-Sars-cov-2 ELISA, and GenScript surrogate virus neutralization assays and examined the humoral response associated with vaccination.
BASIC—LIVER, PANCREAS, AND BILIARY TRACT Silymarin Inhibits In Vitro T-Cell Proliferation and Cytokine Production in Hepatitis C Virus Infection
Chihiro Morishima,Margaret C. Shuhart,Chia C. Wang,Denise M. Paschal,Minjun C. Apodaca,Yanze Liu,Derek D. Sloan,Tyler N. Graf,NH Oberlies,Keith R. Jerome,Stephen J. Polyak +10 more
TL;DR: Silymarin’s ability to inhibit the proliferation and proinflammatory cytokine secretion of T cells, combined with its previously described antiviral effect, suggests a possible mechanism of action that could lead to clinical benefit during HCV infection.